CIBC Private Wealth Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $743M | Sell |
4,040,909
-36,165
| -0.9% | -$6.34M | 1.26% | 12 |
|
|
2025
Q3 | $626M | Sell |
4,077,074
-39,107
| -1% | -$5.92M | 1.07% | 13 |
|
|
2025
Q2 | $575M | Buy |
4,116,181
+6,749
| +0.2% | +$946K | 1.03% | 13 |
|
|
2025
Q1 | $533M | Buy |
4,109,432
+56,434
| +1% | +$8.16M | 1.13% | 12 |
|
|
2024
Q4 | $540M | Sell |
4,052,998
-492,181
| -11% | -$68.9M | 0.98% | 15 |
|
|
2024
Q3 | $708M | Sell |
4,545,179
-61,215
| -1% | -$9.88M | 1.27% | 11 |
|
|
2024
Q2 | $711M | Sell |
4,606,394
-40,998
| -0.9% | -$6.17M | 1.33% | 10 |
|
|
2024
Q1 | $625M | Sell |
4,647,392
-565,065
| -11% | -$74.8M | 1.22% | 13 |
|
|
2023
Q4 | $709M | Buy |
5,212,457
+444,589
| +9% | +$57.8M | 1.5% | 9 |
|
|
2023
Q3 | $646M | Sell |
4,767,868
-219,082
| -4% | -$29.9M | 1.53% | 9 |
|
|
2023
Q2 | $714M | Buy |
4,986,950
+31,604
| +0.6% | +$4.65M | 1.56% | 7 |
|
|
2023
Q1 | $688M | Sell |
4,955,346
-428,858
| -8% | -$57.7M | 1.52% | 13 |
|
|
2022
Q4 | $417M | Sell |
5,384,204
-22,766
| -0.4% | -$2.86M | 1.4% | 14 |
|
|
2022
Q3 | $593M | Buy |
5,406,970
+41,588
| +0.8% | +$5.28M | 1.6% | 9 |
|
|
2022
Q2 | $709M | Buy |
5,365,382
+745,083
| +16% | +$97.8M | 1.84% | 7 |
|
|
2022
Q1 | $613M | Buy |
4,620,299
+624,450
| +16% | +$74.9M | 1.34% | 10 |
|
|
2021
Q4 | $466M | Buy |
3,995,849
+316,883
| +9% | +$37.3M | 0.97% | 20 |
|
|
2021
Q3 | $442M | Buy |
3,678,966
+348,754
| +10% | +$40.6M | 1.03% | 18 |
|
|
2021
Q2 | $399M | Buy |
3,330,212
+121,807
| +4% | +$13.4M | 0.92% | 23 |
|
|
2021
Q1 | $319M | Buy |
3,208,405
+846,532
| +36% | +$85.1M | 0.8% | 32 |
|
|
2020
Q4 | $236M | Buy |
2,361,873
+471,477
| +25% | +$49.9M | 0.62% | 48 |
|
|
2020
Q3 | $207M | Buy |
1,890,396
+1,882,712
| +24,502% | +$209M | 0.63% | 49 |
|
|
2020
Q2 | $813K | Sell |
7,684
-304,444
| -98% | -$31.4M | ﹤0.01% | 482 |
|
|
2020
Q1 | $27.9M | Sell |
312,128
-2,887
| -0.9% | -$272K | 0.12% | 144 |
|
|
2019
Q4 | $31.4M | Buy |
315,015
+4,695
| +2% | +$442K | 0.1% | 158 |
|
|
2019
Q3 | $27.7M | Buy |
310,320
+667
| +0.2% | +$57.8K | 0.1% | 170 |
|
|
2019
Q2 | $25.6M | Sell |
309,653
-16,417
| -5% | -$1.29M | 0.09% | 188 |
|
|
2019
Q1 | $26.4M | Sell |
326,070
-289,625
| -47% | -$22.8M | 0.1% | 174 |
|
|
2018
Q4 | $46.8M | Buy |
615,695
+402,992
| +189% | +$31.5M | 0.21% | 126 |
|
|
2018
Q3 | $16.8M | Buy |
212,703
+211,279
| +14,837% | +$16M | 0.06% | 230 |
|
|
2018
Q2 | $100K | Buy |
1,424
+279
| +24% | +$20.1K | ﹤0.01% | 1028 |
|
|
2018
Q1 | $80K | Sell |
1,145
-4,640
| -80% | -$321K | ﹤0.01% | 1061 |
|
|
2017
Q4 | $402K | Buy |
+5,785
| New | +$390K | ﹤0.01% | 824 |
|
|
2016
Q1 | – | Sell |
-6,620
| Closed | -$449K | – | 580 |
|
|
2015
Q4 | $449K | Buy |
6,620
+142
| +2% | +$9.31K | ﹤0.01% | 535 |
|
|
2015
Q3 | $412K | Buy |
+6,478
| New | +$426K | ﹤0.01% | 548 |
|
Other funds holding AZN
CIBC Private Wealth Group's AZN Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its AstraZeneca (AZN) stake by 0.89% in Q4 2025, selling an estimated $6.34M and leaving 4,040,909 shares worth $743M. The position accounts for 1.26% of the portfolio, ranked #12.
CIBC Private Wealth Group first reported a position in AZN in Q3 2015 and has held it in 35 quarters since. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.
- CIBC Private Wealth Group held 4,040,909 shares of AstraZeneca worth $743M as of Q4 2025.
- CIBC Private Wealth Group sold 36,165 AstraZeneca shares in Q4 2025, an estimated $6.34M.
- AstraZeneca made up 1.26% of CIBC Private Wealth Group's portfolio in Q4 2025, its #12 holding.
- CIBC Private Wealth Group first reported a position in AstraZeneca in Q3 2015 and has held it in 35 quarters since.
- 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.